Clearance of an epidemic clone of methicillin-resistant Staphylococcus aureus in a drug-use network: A follow-up study in Switzerland

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 9, 2012, Pages 650-655

  Colombo, Carlo ^a   Senn, Gabriela ^a   Bürgel, Anne ^a   Ruef, Christian ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Drug users; Epidemic clone; MRSA; Prevalence; Public health

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DIAMORPHINE; FUSIDIC ACID; METHADONE;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; CLONAL EVOLUTION; DEMOGRAPHY; EMERGENCY HEALTH SERVICE; EPIDEMIC; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE SMEAR; PREVALENCE; SWITZERLAND; THROAT CULTURE; WOUND;

ADOLESCENT; ADULT; DRUG USERS; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NASAL CAVITY; PHARYNX; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; SUBSTANCE ABUSE, INTRAVENOUS; SWITZERLAND; WOUNDS AND INJURIES;

EID: 84865316419     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.672766     Document Type: Article

References (32)

1. Scheidegger C, Zimmerli W. Infectious complications in drug abuse: seven year review of 269 hospitalized narcotics abusers in Switzerland. Rev Infect Dis 1989;11:486-93.
2. Tuazon CU, Sheagren JN. Staphylococcal endocarditis in parenteral drug abusers: source of the organism. Ann Intern Med 1975;82:788-90.
3. Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med 1993;119:1017-27.
4. Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med 2005;353:1945-54. (Pubitemid 41568603)
5. Berman DS, Schaefler S, Simberkoff MS, Rahal JJ. Staphylococcus aureus colonization in intravenous drug abusers, dialysis patients, and diabetics. J Infect Dis 1987;155:829-31.
6. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mech anisms, and associated risks. Clin Microbiol Rev 1997;10:505-20. (Pubitemid 27359263)
7. Bassetti S, Battegay M. Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies. Infection 2004;32:163-9. (Pubitemid 38757022)
8. Quagliarello B, Cespedes C, Miller M, Toro A, Vavagiakis P, Klein RS, et al. Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis 2002;35:671-7. (Pubitemid 35024726)
9. Al-Rawahi GN, Schreader AG, Porter SD, Roscoe DL, Gustafson R, Bryce EA. Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later. J Clin Microbiol 2008;46:477-9. (Pubitemid 351231289)
10. Gilbert M, MacDonald J, Gregson D, Siushansian J, Zhang K, Elsayed S, et al. Outbreak in Alberta of communityacquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 2006;175:149-54. (Pubitemid 44126248)
11. Fleisch F, Zbinden R, Vanoli C, Ruef C. Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland. Clin Infect Dis 2001;32:581-6. (Pubitemid 32564998)
12. Colombo C, Zink R, Ruef C. Persistence of a methicillinresistant Staphylococcus aureus clone in a drug-use network. Clin Infect Dis 2003;37:990-1.
13. Fleisch F, Oechslin EC, Gujer AR, Ritzler E, Imhof A, Ruef C, et al. Transregional spread of a single clone of methicillinresistant Staphylococcus aureus between groups of drug users in Switzerland. Infection 2005;33:273-7. (Pubitemid 41152189)
14. Qi W, Ender M, O' Brien F, Imhof A, Ruef C, McCallum N, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Zurich, Switzerland (2003): prevalence of type IV SCC mec and a new SCC mec element associated with isolates from intravenous drug users. J Clin Microbiol 2005;43:5164-70. (Pubitemid 41484021)
15. Ender M, Berger-Bä chi B, McCallum N. Variability in SCC mec N1 spreading among injection drug users in Zurich, Switzerland. BMC Microbiol 2007;7:62.
16. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, et al. Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. JAMA 2010;304:641-8.
17. European Antimicrobial Resistance Surveillance System (EARSS). Annual report 2009. Bilthoven, the Netherlands: EARSS; 2010. Available at: http://www.rivm.nl/earss/Images/EARSS%202008-final-tcm61-65020.pdf (accessed 18 August 2011).
18. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100-S16. 16 th ed. Wayne, PA: CLSI; 2006.
19. Holbrook KA, Klein RS, Hartel D, Elliott DA, Barsky TB, Rothschild LH, et al. Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16: 301-6.
20. Craven DE, Rixinger AI, Goularte TA, McCabe WR. Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a " shooting gallery ". Am J Med 1986;80:770-6. (Pubitemid 16033694)
21. Safdar N, Narans L, Gordon B, Maki DG. Comparison of culture screening methods for detection of nasal carriage of methicillin-resistant Staphylococcus aureus: a prospective study comparing 32 methods. J Clin Microbiol 2003;41: 3163-6. (Pubitemid 36842316)
22. Brayshaw PD. Methicillin-resistant Staphylococcus aureus: evaluation of detection techniques on laboratory-passaged organisms. Br J Biomed Sci 1999;56:170-6.
23. Grmek-Kosnik I, Ihan A, Dermota U, Rems M, Kosnik M, Jorn Kolmos H. Evaluation of separate vs pooled swab cultures, different media, broth enrichment and anatomical sites of screening for the detection of methicillin-resistant Staphylococcus aureus from clinical specimens. J Hosp Infect 2005; 61:155-61. (Pubitemid 41283340)
24. Mertz D, Frei R, Jaussi B, Tietz A, Stebler C, Flückiger U, et al. Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus. Clin Infect Dis 2007;45:475-7. (Pubitemid 47204465)
25. Nordt C, Stohler R. Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis. Lancet 2006; 367:1830-4. (Pubitemid 43833193)
26. Maffl E, Jordan MD, Schaaf S, Schaub M, Künzi U, Eastus CH. Act-info Jahresbericht 2008. Suchtberatung und Suchtbehandlung in der Schweiz Ergebnisse des Monitoringsystems. Bundesamt für Gesundheit 2009;1-67.
27. Ruef C, Ruef SA, Senn G, Cathomas A, Imhof A. Decolonisation of patients with wounds colonised by MRSA. J Hosp Infect 2009;72:88-90.
28. Buehlmann M, Frei R, Fenner L, Dangel M, Fluckiger U, Widmer AF. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol 2008;29:510-6. (Pubitemid 351918029)
29. Klingemann HK. Drug treatment in Switzerland: harm reduction, decentralization and community response. Addiction 1996;91:723-36. (Pubitemid 26146462)
30. Savary JF, Hallam C, Bewley-Taylor D. The Swiss Four Pillars policy: an evolution from local experimentation to federal law. The Beckley Foundation Drug Policy Programme; 2009. Available at: http://www.idpc.net/sites/default/files/ library/Beckley-Briefing-18.pdf (accessed 17 August 2011).
31. Zingg W, Colombo C, Jucker T, Bossart W, Ruef C. Impact of an outbreak of norovirus infection on hospital resources. Infect Control Hosp Epidemiol 2005;26:263-7. (Pubitemid 40445084)
32. Simoens S, Ophals E, Schuermans A. Search and destroy policy for methicillin-resistant Staphylococcus aureus: cost-benefi t analysis. J Adv Nurs 2009;65:1853-9.